Archive for July, 2010

“Pensions are sustainable and value for money”

By Mike Broad - 30th July 2010 8:46 am

The NHS pension scheme is sustainable and represents value for money for the public, the BMA has told an independent commission into public sector pensions.

The BMA points out that the NHS scheme is financed by employees and employers rather than taxpayers, and in recent years has provided a surplus to the Treasury.

Its submission also reminds the commission that the scheme for NHS staff in England and Wales was recently subject to a major review. In 2008 the normal pension age for new staff increased from 60 to 65, employers’ contributions were capped, and contributions from doctors increased by up to 2.5%. GP members of the scheme also pay employer contributions of 14%.

Dr Andrew Dearden, chairman of the BMA’s pensions committee, said: “Pensions for NHS staff are by no means a drain on the taxpayer - they represent a fair deal for staff and value for money for the public. We understand the need to keep the NHS scheme fair and sustainable in the long term, which is why we accepted the major changes recommended by the review in 2008.

“NHS pensions play a vital part in recruiting and retaining a high quality workforce in future, and we hope they will continue to do so in future.”

The commission, chaired by former Labour minister Lord Hutton, has been tasked with assessing the growing gap between public and private sector pensions provision, the need for fairness across the workforce and how risk should be shared between the taxpayer and the employee.

There are no plans to undermine existing accrued pension rights, but the commission is expected to recommend how pensions can be made “sustainable and affordable in the long-term”.

In its submission, the HCSA pointed out that doctors’ pensions were already suffering. “From April 2010 no increase was awarded to consultants - in advance of the announced ‘public sector pay freeze’ that will affect our members for the two years from April 2011.

“Similarly, the level of Clinical Excellence Awards were not increased this April. Consultants therefore face a freeze on pensionable pay for three years.”

The HCSA also countered rumours. “We would oppose a reduction in the annual maximum contribution allowed. Suggestions are that this could be reduced to £30,000 or £45,000.

“With the NHS pension scheme in surplus we do not see the justification presently for any review of, or increase in, contribution rates. As ‘high earners’ HCSA members contribute more in real monetary terms to the cost of the pension scheme due to the tiered contributions basis in place since April 2008.”

The commission will publish its final report in time for the 2011 Budget.

Deputy Prime Minister Nick Clegg recently criticised “unreformed gold plated” public sector pensions, as new figures show spending on them will more than double by 2014/15.

The Office for Budget Responsibility says the taxpayer cost is set to rise from £4bn to £9bn.

Fears public health may be hit in shake-up of NHS

BBC Health - 29th July 2010 10:24 am

The overhaul of the NHS may harm the public health drive, experts fear.

Under government plans, primary care trusts in England will be abolished and GPs given control of the budget.

The shake-up will also mean public health is handed to councils, but the King’s Fund health think tank said this could lead the NHS to turn its back on issues like smoking and drinking.

The government said it would be setting out detailed plans for public health in England later this year.

Public health has traditionally been the responsibility of local health managers working for the 151 PCTs.

Read more at BBC Health.

Recession hit insurers pressurise consultants

By Francesca Robinson - 8:34 am

Consultants are at loggerheads with private medical insurers over attempts to regulate their private professional practice and drive down fees.

BUPA has angered specialists by insisting on monitoring the professional standards of newly appointed consultants and the way they run their private practices.

The insurer launched a new contract three weeks ago which requires consultants to provide information about their clinical practice including, appraisals, audits and outcome data and also about their practice administration. It also imposes fixed fee schedules on them.

Mr Geoffrey Glazer, chairman of the Federation of Independent Practitioner Organisations (FIPO), accused BUPA of acting as a regulator.

He said the stance was vehemently opposed by most FIPO members. Over 90% of consultants who responded to a survey said that insurers did not have either the capability or the right to act as regulators.

“There was a strong sense (among 95.7% of respondents) that an insurer should not be responsible for monitoring the progress, appraisal and audit results of newly appointed consultants or indeed for any consultants.” This was part of the process of revalidation and came under the remit of the GMC, not a financial services company such as BUPA, said Glazer.

Significant numbers of specialists are also reporting problems with de-listing, capping and lack of recognition, another survey by the Independent Doctors Federation (IDF) has revealed.

More than 10% of the 224 IDF specialists who responded reported that they had been de-listed by an insurer; 36 reported a problem with recognition and 92 had had their fees capped.

AXA PPP and BUPA headed the list on both capping and de-listing issues with disagreement over fees cited as the major cause of their actions. IDF claims there have been widespread examples of inconsistency and lack of transparency in the application of these sanctions.

IDF chairman Dr Jack Edmonds said doctors who had been de-listed, capped or not recognised had often had previous reputations for excellence but were being suddenly disciplined by insurers “on a whim” for having the “temerity” to stand up for their independence.

Insurers were blaming “expensive doctors” for their current financial problems. But their profits were currently being hit by downward pressure on premiums, a reduction in clients, medical inflation and overheads charged by private hospitals. Doctors’ fees had generally remained static over the last five years.

“The private medical insurers have failed to discuss these issues, have not published transparent codes of practice and have not treated specialist doctors on a consistent or like for like basis. At the moment they seem intent on dictating their terms without negotiation or dialogue,” said Edmonds.

These concerns follows pressure from both BUPA and AXA PPP - who between them control 70% of the private medical insurance market - to impose financial penalties on patients who wish to see a consultant of their choice instead of a cheaper ‘recommended’ consultant. Private practice organisations say this harms the patient-consultant relationship, impacts on established care/referral pathways and restricts patient access to the most appropriate specialist.

Katrina Herren, medical director of BUPA Health and Wellbeing UK, said hundreds of specialists had already signed up for their contract for newly appointed consultants.

The contract only asked consultants to tick a box and to provide a date on an online form to let them know that they were abiding by the regulatory processes of the GMC. One of the reasons it introduced this was because there were gaps in plans for the regulation of consultants working solely in private practice. Consultants had specifically asked them to recognise specialists who do not hold substantive NHS posts.

“We just want to make sure that these consultants are abiding by the recommendations of the GMC as they are self-employed individuals. It’s very much easier and fair if we treat everybody in the same way,” she said.

She said it was asking consultants about administrative issues, such as how long patients had to wait for appointments or whether they could easily get hold of a secretary, because these were quality concerns that were important to the patients in the private sector.

Herren said the pressure to keep costs under control, which was particularly important to their corporate members, was the reason they had to sign up new consultants to fixed fee schedules. “One of things we are trying to do is balance the needs of people who would like to be paid a lot more with needs of large corporations who want to keep medical insurance products open to as many members of staff as possible.”

No consultant, she said, had been de-listed because they had refused to reduce their fees.

New figures from the consultancy Lang and Buisson show that demand for private medical insurance fell by record levels last year.

Deprivation of liberty safeguards under used

By Mike Broad - 7:55 am

Hospitals and care homes are making less than expected use of new measures designed to protect people unable to consent to their care or treatment, a report says.

Deprivation of liberty safeguards were introduced by law on 1 April 2009 to provide a legal framework for depriving someone of their liberty where they are unable to give informed consent regarding their care.

The report on data from 2009/2010 provides the first official information about use of the new arrangements.

The total number of applications made was much lower than expected (7,160 in England compared with the number predicted of 21,000 for England and Wales).

Although the number of successful applications resulting in an authorisation to deprive a person of their liberty was lower than expected (3,300 in England compared to the 5,000 predicted for England and Wales), a much higher percentage of applications than expected were successful (46% compared with the predicted 25%).

The majority of applications (3,645 out of 7,160) were for a person who lacked capacity because of dementia.

The Mental Capacity Act Deprivation of Liberty Safeguards came into force on 1 April 2009, and provides a legal framework to prevent the unlawful deprivation of a person’s liberty occurring.

The arrangements protect people who are vulnerable to abuse and poor care while residing in a hospital or care home through the use of a standardised assessment and authorisation process.

They can be used if someone lacks capacity, such as the severely learning disabled or with advanced dementia, to consent to arrangements made for their care or treatment but who needs to be deprived of their liberty for their own best interests.

They offer the person concerned the right to challenge any decision to deprive them of liberty, a representative to act for them and protect their interests and the right to have their status reviewed and monitored on a regular basis.

The report reveals that about 4% of applications that were not authorised involved situations where the person was nevertheless judged as being in a situation that amounted to a deprivation of liberty.

It says: “In these cases the hospitals and care homes could be acting illegally if the person was not swiftly cared for or treated in less restrictive circumstances.”

Read the full report.

“Improvement still needed at Mid Staffs”

Healthcare Republic - 28th July 2010 3:35 pm

The Care Quality Commission (CQC) has announced further improvement is needed at Mid-Staffordshire NHS Foundation Trust, a year after it was revealed that hundreds of patients had died unnecessary deaths at the hospital.

Following a review of care at the trust, the CQC acknowledged ‘significant improvement’ but said there were still concerns about staff absences and waiting times in A&E.

‘Mortality rates are declining, there are more nurses, and patients are generally positive about their care,’ the review concludes.

Read more at Healthcare Republic.

Emergency fund to fast-track cancer drugs

BBC Health - 3:00 pm

The government has announced a £50m fund which should give very sick cancer patients access to drugs sooner.

It will mean that from October, rather than next year, doctors in England can offer drugs which have not been approved by the rationing body NICE.

The announcement was made at the launch of a study showing that the UK lags in providing the newest cancer drugs.

The fund will be financed by ditching the former government’s plan for free personal care for the old.

It means that cancer patients will be able to access new drugs earlier to help extend life by weeks or months or improve quality of life in the final stages of the disease.

The government’s cancer tsar Professor Sir Mike Richards, who led the research into the UK’s ranking on drug provision, stressed however it would not improve overall survival rates.

Read more at BBC Health.

All trainees should know their contractual rights

By Dr Ayesha Rahim, deputy chair of the BMA’s junior doctors committee - 9:48 am

When I first qualified in 2003 I found the transition from medical student to junior doctor pretty challenging. Apart from getting used to the increased demands in time and energy of my clinical role, I also had to learn to juggle working full-time with my postgraduate studies and personal life.

I remember being vaguely aware of the fact that I had a contract of employment, but not really being sure of what was contained in it. One thing I do recall clearly however, was the frequent feeling of frustration when there was a mismatch between what I thought my contract said should happen, and what was actually happening in practice.

For example, I didn’t feel particularly confident in standing my ground when it came to what I was entitled to regarding the standard of my accommodation, sick-leave or correcting problems with my payslip. On top of that, I didn’t know where I’d find the time to inform myself of my contractual rights. That’s when I decided to look for guidance on my Terms and Conditions of Service, a complex document that lays out what should and shouldn’t happen regarding my working conditions.

With some assistance I’ve resolved a number of issues over the years, such as an incorrect incremental date on my payslip leading to significant back pay when corrected, and issues with monitoring and re-banding.

As junior doctors in the modern NHS, there are many demands on our time: our day-to-day clinical tasks, our out-of-hours commitments and all the associated activities of training such as appraisal and assessment. There are many provisions within our contract that can help make our working lives a little less stressful and a little more manageable.

Having this information at our fingertips in an easily accessible format can help us all focus on what we really want to do - to practise as doctors, while maintaining a healthy work-life balance. If we are well informed of our rights, we can ensure that we get fair treatment for a fair day’s work.

As it stands, there is still much confusion about many contractual issues, such as monitoring hours of work. It will come as no surprise that this is one of the most common queries we get asked about. Currently, most people “pick it up as they go along” when it comes to information about contractual rights. What I would like to see happen is for us to be equipped with this knowledge before we need it. Every final year medical student should be able to start work with a sound understanding of what their contract says, and every junior doctor should know where to get additional information about what they’re entitled to.

I feel strongly about junior doctors asserting their contractual rights and that is why, as chairman of the BMA junior doctors committee negotiating team, I’ve worked hard to put together the key entitlements of the current contract in a way which I hope is comprehensive, accessible and above all, helpful.

The JDC has put together a summary of the key entitlements of the current contract, which explains your rights in a simple and digestible way. Read more here.

Final warning as Revenue runs out of patience

Healthcare Republic - 27th July 2010 3:58 pm

Doctors with undisclosed tax problems have been urged to come forward “quickly” after only 1,500 of a potential 30,000 medical professionals took advantage of a tax amnesty scheme.

Earlier this year the HM Revenue and Customs launched its tax health plan (THP) sending letters to 30,000 medical professionals that it believed could have potential problems with their tax.

It said that if doctors come forward voluntarily face they will face a tax penalty of just 10% of the amount of tax owed.

If they do not take the opportunity offered under the THP, doctors could face a maximum of 100% of the tax owed (on top of full repayment of the debt and interest charged on it).

The Revenue is now urging more doctors to come forward ahead of 1 August before full investigations begin.

Read more at Healthcare Republic.

Diabetes costs in the NHS “spiralling out of control”

BBC Health - 3:54 pm

The NHS is spending too much on diabetes drugs say researchers, who found the medicines account for 7% of the UK prescribing budget.

A big rise in the number of people with type 2 diabetes in recent years does not fully explain the spiralling costs, say Cardiff University researchers. With rates of the condition expected to rise further, the NHS needs to get the budget under control, they conclude.

In 2008 the NHS spent £700m on drugs to control blood sugar, figures show.

The researchers calculated that between 2000 and 2008 the number of prescriptions for glucose-lowering drugs had risen by 50%. But costs, even taking into account the price of inflation, rose by 104%, they said.

Writing in the journal Diabetic Medicine, they said figures for England specifically show an increase from £290m to £591m over the study period.

Read more at BBC Health.

NHS will continue to fund homeopathy

By Mike Broad - 1:13 pm

Homeopathy will continue to be available on the NHS, the government has said in response to a House of Commons science and technology committee report.

That report recommended that homeopathy should no longer be available on the NHS because of the lack of evidence of its efficacy.

Despite the NHS needing to make significant savings, the government responded that it was up to local clinicians to decide whether homeopathic treatments were appropriate.

The government says: “We believe in patients being able to make informed choices about their treatments, and in a clinician being able to prescribe the treatment they feel most appropriate in particular circumstances, within the regulatory and guidance frameworks by which they are bound.”

It adds: “Our continued position on the use of homeopathy within the NHS is that the local NHS and clinicians, rather than Whitehall, are best placed to make decisions on what treatment is appropriate for their patients - including complementary or alternative treatments such as homeopathy - and provide accordingly for those treatments.”

There was strong support for stopping the NHS funding and commissioning of homeopathic remedies from doctors attending the recent Annual Representatives Meeting of the BMA.

Dr Mary McCarthy proposed a motion which said scarce NHS resources should not be spent on treatments that “have no firm evidence base”.

She said: “Let’s leave homeopathy to be funded by those who want to use it and who believe in it, and leave NHS scarce resources for proven medical treatments.”

A separate strand of the motion, which called for pharmacists to place homeopathic remedies on shelves labelled ‘placebos’, was also carried.

The government response does call for the scientific evidence for homeopathy, or lack of it, to be explained and available to patients.

It says: “[The Chief scientific adviser] has concerns about how this policy is communicated to the public. There naturally will be an assumption that if the NHS is offering homeopathic treatments then they will be efficacious, whereas the overriding reason for NHS provision is that homeopathy is available to provide patient choice.”

Read the government’s full response.